drugset / Trial / NCT01822600
The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
Phase 4
Completed
91 enrolled
National Cheng-Kung University Hospital
National Science and Technology Council, Taiwan · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To test whether intravenous albumin can decrease the rebleeding rate or shorten the duration of hospitalization in patients with peptic ulcer bleeding and hypoalbuminemia.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | 10 g | Intravenous |
| Background | Esomeprazole | Small molecule | 40 mg | Oral |
| Background | Omeprazole | Other / unclassified | 20 mg | Intravenous |